biotech

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part II-Birth, Adolescence, and Adulthood

The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead.

MNCs in the News-2018-04-20

China to roll out new negative lists for free-trade zones (FTZs) and other parts of the country during the first half of 2018. Foreign and publicly-listed on foreign exchanges Chinese firms move to accommodate Chinese Communist Party (CCP)’s desire for greater say. China’s Ministry of Commerce (MOFCOM) touts that Chinese outward foreign direct investment (FDI) grew while Chinese outward FDI in irrational areas has collapsed. Chinese investors pour money into American bio-tech firms for a variety of financial, political, and social policy reasons. Indonesia to rely on loans from Japanese government and public-private partnership schemes to fund USD $4.5 billion railway project. Honda experiencing complications with its CR-V recall plan in China as sales continue to drop. Seoul offers to give American carmaker General Motors USD $470 million to continue its Korean operations as bankruptcy looms. Multinational companies operating in South Korea increasingly under government scrutiny for malpractice. AIIB very interested in financing Malaysian infrastructure projects following a meeting between the AIIB President and Malaysia’s Prime Minister. Japan’s Nichirei Corp acquires 40 percent stake in Malaysia’s state-owned Cold Chain Network which facilitates the latter’s effort to address government development objectives.